Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Zhong Ji Longevity Science Group Limited ( (HK:0767) ) has shared an announcement.
Zhong Ji Longevity Science Group Limited announced a technology promotion agreement between its subsidiary, Zhongli, and Beijing Sanyouli Heze Biotechnology Co., Ltd. The collaboration aims to promote technology applications for treating periodontitis using allogeneic dental pulp mesenchymal stem cell injections within the Boao Lecheng International Medical Tourism Pilot Zone. This agreement positions Zhongli as a key promoter of the DPSC Project, enabling it to expand its market operations and commercialize the technology globally, in compliance with national regulations.
More about Zhong Ji Longevity Science Group Limited
Zhong Ji Longevity Science Group Limited is an investment holding company incorporated in Bermuda, primarily engaged in the longevity science business, money lending and financial advisory services, and securities, property, and investment business. Its subsidiary, Zhongli, focuses on providing longevity health services in the PRC.
Average Trading Volume: 1,097,301
Technical Sentiment Signal: Buy
Current Market Cap: HK$296M
See more data about 0767 stock on TipRanks’ Stock Analysis page.